Jointown Pharmaceutical Group Company Limited’s Net Profit Dropped 39.4% in First Half of 2022

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 1.4 billion yuan in the first half of 2022, down 39.4% year-on-year.

Meanwhile, the company posted 68 billion yuan in revenue, up 9.7% year-on-year.

At the end of the reporting period, it had 90.7 billion yuan in total assets and 63 billion yuan in total liabilities, with a liability-to-asset ratio of 69.5%.